| Thiotepa studied in …STUDIED_INderived182 of 182show fewer |
|---|
| → studied in | NCT03779854Phase 2 · active not recruiting Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant · 182 trials list this drug (37 active) | — | — | Acute Leukemia,Acute Lymphoblastic Leukemia,Burkitt Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01511562Phase 2 · completed Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma · 182 trials list this drug (37 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06172296Phase 3 · recruiting Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma · 182 trials list this drug (37 active) | — | — | Neuroblastoma,Ganglioneuroblastoma, Nodular | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04684368Phase 2 · recruiting A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT · 182 trials list this drug (37 active) | — | — | Mixed Germ Cell Tumor,Central Nervous System Nongerminomatous Germ Cell Tumor,Choriocarcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03849651Phase 2 · active not recruiting TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies · 182 trials list this drug (37 active) | — | — | Acute Lymphoblastic Leukemia,Hodgkin Lymphoma,Juvenile Myelomonocytic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06680661Phase 2 · suspended ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis · 182 trials list this drug (37 active) | — | — | Lymphoma,Acute Lymphoblastic Leukemia,Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01949129Phase 2/Phase 3 · recruiting Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia · 182 trials list this drug (37 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06687772Phase 2 · recruiting CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant · 182 trials list this drug (37 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07257419Phase 1 · recruiting CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma · 182 trials list this drug (37 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Childhood Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03126916Phase 3 · recruiting Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL) · 182 trials list this drug (37 active) | — | — | Ganglioneuroblastoma,Neuroblastoma,Ganglioneuroblastoma, Nodular | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06158828Phase 1/Phase 2 · recruiting Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML · 182 trials list this drug (37 active) | — | — | Acute Myeloid Leukemia,Childhood Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07778940Phase 2 · not yet recruiting Thiotepa Administration Via Ommaya Reservoir for Leptomeningeal Metastases in Non-Small Cell Lung Cancer Resistant to EGFR-TKI. · 182 trials list this drug (37 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07565220Phase 1 · recruiting Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies · 182 trials list this drug (37 active) | — | — | Acute Leukemia,Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07759102Phase 1 · not yet recruiting Allogeneic ORCA-Q Stem Cell Transplant for the Treatment of Relapsed and Refractory High Risk Multiple Myeloma · 182 trials list this drug (37 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04708054Phase 2/Phase 3 · recruiting Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS · 182 trials list this drug (37 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02861417Phase 2 · active not recruiting Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant · 182 trials list this drug (37 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Acute Lymphoblastic Leukemia,Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05457556Phase 3 · active not recruiting Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome · 182 trials list this drug (37 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06013423Phase 2 · recruiting Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases · 182 trials list this drug (37 active) | — | — | Hematopoietic and Lymphatic System Neoplasm,Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06942039early Phase 1 · recruiting Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation · 182 trials list this drug (37 active) | — | — | Central Nervous System Embryonal Tumor,Atypical Teratoid/Rhabdoid Tumor,Central Nervous System Embryonal Tumor with Rhabdoid Features+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03399773Phase 2 · active not recruiting Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes · 182 trials list this drug (37 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03786783Phase 2 · completed Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma · 182 trials list this drug (37 active) | — | — | Ganglioneuroblastoma,High Risk Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07052370Phase 1 · recruiting TCRαβ-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of Blinatumomab, in naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies · 182 trials list this drug (37 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02220985Phase 2 · completed Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD · 182 trials list this drug (37 active) | — | — | Acute Lymphoblastic Leukemia,Lymphoblastic Lymphoma,Acute Leukemia of Ambiguous Lineage+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07566377Phase 2 · recruiting Cord Blood Transplantation in Children and Young Adults With Blood Cancer · 182 trials list this drug (37 active) | — | — | Leukemia,Lymphoma,Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05088356Phase 1 · active not recruiting Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft · 182 trials list this drug (37 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Acute Leukemia,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04872595Phase 2 · active not recruiting A Modified Dose of Rabbit Anti-thymocyte Globulin (rATG) in Children and Adults Receiving Treatment to Help Prepare Their Bodies for a Bone Marrow Transplant · 182 trials list this drug (37 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04217278Phase 2/Phase 3 · active not recruiting A Trial of Treatments to Assess the Effects on Outcome of Adults With AML and MDS Undergoing Allogeneic SCT · 182 trials list this drug (37 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07563920NA · not yet recruiting TBF Conditioning Regimen for Haploidentical Stem Cell Transplantation in Elderly AML Patients in First Complete Remission · 182 trials list this drug (37 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06195891Phase 1 · recruiting Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome · 182 trials list this drug (37 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06807606Phase 2 · recruiting Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation · 182 trials list this drug (37 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01011920Phase 2 · completed Trial for Patients With Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma · 182 trials list this drug (37 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03970096Phase 2 · recruiting Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS) · 182 trials list this drug (37 active) | — | — | Acute Leukemia,Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05565105Phase 2 · not yet recruiting CD34+ Transplants for Leukemia and Lymphoma · 182 trials list this drug (37 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07441967Phase 2 · not yet recruiting The Safety and Efficacy of the Regimen of Thiotepa + Fludarabine +Granulocyte Colony-Stimulating Factor+ Cytarabine + Busulfan in Single Unrelated Umbilical Cord Blood Transplantation · 182 trials list this drug (37 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06252870Phase 2 · recruiting Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation · 182 trials list this drug (37 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00336024Phase 3 · completed Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma · 182 trials list this drug (37 active) | — | — | Medulloblastoma,Anaplastic Medulloblastoma,Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01746849Phase 2 · active not recruiting Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation · 182 trials list this drug (37 active) | — | — | Leukemia,Multiple Myeloma,Myelodysplastic Syndrome+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02870907Phase 2 · active not recruiting Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009) · 182 trials list this drug (37 active) | — | — | Retinoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07276737Phase 2 · not yet recruiting Preconditioning With a Combination of Thiotepa, Cyclophosphamide, and Busulfan for Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of NK/T-Cell Lymphoma · 182 trials list this drug (37 active) | — | — | Nasal Type Extranodal NK/T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03342196Phase 2 · completed Thiotepa Plus Fludarabine+ Melphalan as the Preparative Regime for Alternative Donor Transplantation · 182 trials list this drug (37 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02605421Phase 2 · recruiting Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma · 182 trials list this drug (37 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04678401Phase 1 · recruiting IS-free Treg HaploHCT · 182 trials list this drug (37 active) | — | — | Myelodysplastic Syndrome,Myeloid Leukemia,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05579769Phase 2 · terminated Pediatric Study of GVHD Ppx w/o Calcineurin Inhibitors After Day60 Post First Allo HSCT for Hematological Malignancies. · 182 trials list this drug (37 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02790515Phase 2 · active not recruiting Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation · 182 trials list this drug (37 active) | — | — | Myeloid Sarcoma,Acute Lymphoblastic Leukemia,Juvenile Myelomonocytic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02329080Phase 2 · completed New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System Involvement · 182 trials list this drug (37 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04530487Phase 2 · terminated Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults · 182 trials list this drug (37 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,Malignant Solid Neoplasm,Malignant Peripheral Nerve Sheath Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01350258Phase 1/Phase 2 · terminated Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps · 182 trials list this drug (37 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Acute Leukemia,Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03615105Phase 2 · terminated Donor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched Donors · 182 trials list this drug (37 active) | — | — | Acute Lymphoblastic Leukemia,Hodgkin Lymphoma,Non-Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00719888Phase 2 · completed Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease · 182 trials list this drug (37 active) | — | — | Acute Lymphoblastic Leukemia,Lymphoblastic Lymphoma,Multiple Myeloma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04083170Phase 2 · terminated Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers · 182 trials list this drug (37 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02880293NA · completed Haploidentical (Half-matched) Related Donor Stem Cell Transplantation Using Killer Immunoglobulin-like Receptors in Addition to Normal Selection Factors to Determine the Best Donor · 182 trials list this drug (37 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04521946Phase 1 · withdrawn Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer · 182 trials list this drug (37 active) | — | — | Primitive Neuroectodermal Tumor,Anaplastic Ependymoma,Atypical Teratoid/Rhabdoid Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04151706Phase 2 · completed CD34 Selected Allogeneic HCT w/ Myeloablative Conditioning Plus CD8+ Memory TCell Infusion in MDS, AL and CML · 182 trials list this drug (37 active) | — | — | Acute Leukemia,Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06468267Phase 2 · unknown RIC With Thiotepa Combined With Bu/Flu/Ara-C in Allo-HSCT for Relapsed or Refractory PTCL. · 182 trials list this drug (37 active) | — | — | Peripheral T-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03346096Phase 2 · completed TEAM (Thiotepa, Etoposide, Cytosar, Melphalan ) for AutoSCT in Lymphoma · 182 trials list this drug (37 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02061800Phase 1/Phase 2 · unknown CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant · 182 trials list this drug (37 active) | — | — | Lymphoma,Acute Lymphoblastic Leukemia,Juvenile Myelomonocytic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00653068Phase 3 · completed Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System · 182 trials list this drug (37 active) | — | — | Childhood Atypical Teratoid/Rhabdoid Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01858740Phase 2 · completed Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children · 182 trials list this drug (37 active) | — | — | Acute Leukemia of Ambiguous Lineage,Adult Acute Lymphoblastic Leukemia,Childhood Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01505569NA · completed Auto Transplant for High Risk or Relapsed Solid or CNS Tumors · 182 trials list this drug (37 active) | — | — | Germ Cell Tumor,Central Nervous System Neoplasm,Hepatoblastoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03609840completed Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients · 182 trials list this drug (37 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00423514Phase 1/Phase 2 · completed Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease · 182 trials list this drug (37 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01807611Phase 2 · completed Haploidentical Donor Hematopoietic Progenitor Cell and NK Cell Transplantation for Hematologic Malignancy · 182 trials list this drug (37 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04282174Phase 2 · withdrawn CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies · 182 trials list this drug (37 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Acute Lymphoblastic Leukemia,Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01119066Phase 2 · completed HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies · 182 trials list this drug (37 active) | — | — | Acute Lymphoblastic Leukemia,Multiple Myeloma,Myelodysplastic Syndrome+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05303727Phase 2 · not yet recruiting Allogeneic Hematopoietic Stem Cell Transplantation for 4/M Neuroblastoma · 182 trials list this drug (37 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00432094Phase 2 · completed Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors · 182 trials list this drug (37 active) | — | — | Childhood Germ Cell Tumor,Teratoma,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00567567Phase 3 · completed Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma · 182 trials list this drug (37 active) | — | — | Neuroblastoma,Regional Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00867178Phase 1 · completed Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System · 182 trials list this drug (37 active) | — | — | Medulloblastoma,Pineoblastoma,Supratentorial Embryonal Tumor, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02660281Phase 1 · completed URMC Related Haplo-identical Donor BMT · 182 trials list this drug (37 active) | — | — | Solid Neoplasm,Lymphoma,Multiple Myeloma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05021770Phase 1/Phase 2 · unknown Orelabrutinib in Combination With Thiotepa in Refractory and Relapsed Primary CNS Lymphoma · 182 trials list this drug (37 active) | — | — | Non-Hodgkin Lymphoma,Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003816Phase 2/Phase 3 · completed Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer · 182 trials list this drug (37 active) | — | — | Adult Solid Neoplasm,Childhood Solid Neoplasm,Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01690520Phase 2 · completed Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes · 182 trials list this drug (37 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03885947Phase 1 · completed VPA Expanded UCB Transplantation for Treatment of Patients With Hematological Malignancies · 182 trials list this drug (37 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Acute Leukemia,Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00536601NA · completed High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors · 182 trials list this drug (37 active) | — | — | Adult Solid Neoplasm,Childhood Solid Neoplasm,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02707393Phase 2/Phase 3 · completed Allogeneic Stem Cell Transplantation for Children With CML · 182 trials list this drug (37 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00790413early Phase 1 · unknown Haploidentical Stem Cell Transplantation in Neuroblastoma · 182 trials list this drug (37 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00914940Phase 2 · terminated Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD · 182 trials list this drug (37 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003086Phase 1/Phase 2 · terminated Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast Cancer · 182 trials list this drug (37 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00566696Phase 2 · completed Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies · 182 trials list this drug (37 active) | — | — | Leukemia,Lymphoma,Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00857389Phase 2 · completed Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies · 182 trials list this drug (37 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01010217Phase 2 · completed Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide · 182 trials list this drug (37 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02784054Phase 2 · unknown Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell Tumor · 182 trials list this drug (37 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003398Phase 4 · completed Bone Marrow Transplantation in Treating Patients With Hematologic Cancer · 182 trials list this drug (37 active) | — | — | Leukemia,Lymphoma,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00382109Phase 3 · completed Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission · 182 trials list this drug (37 active) | — | — | Childhood Acute Lymphoblastic Leukemia,Childhood B Acute Lymphoblastic Leukemia,Childhood T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00376480Phase 1 · completed Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant · 182 trials list this drug (37 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00978471Phase 2 · completed Adjuvant High-Dose Thiotepa and Stem Cell Rescue Associated With Conventional Chemotherapy in Relapsed Osteosarcoma · 182 trials list this drug (37 active) | — | — | Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00067002Phase 2 · completed Randomized Double Cord Blood Transplant Study · 182 trials list this drug (37 active) | — | — | Leukemia,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003194Phase 1 · terminated Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors · 182 trials list this drug (37 active) | — | — | Childhood Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00801931Phase 1/Phase 2 · terminated Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders · 182 trials list this drug (37 active) | — | — | Leukemia,Lymphoma,Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00621036Phase 2 · withdrawn Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma · 182 trials list this drug (37 active) | — | — | Lymphoma,Small Intestinal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002836Phase 3 · completed Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer · 182 trials list this drug (37 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005092Phase 1 · completed Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer · 182 trials list this drug (37 active) | — | — | Leukemia,Lymphoma,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00793845Phase 2 · completed Tandem High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients With High-risk Neuroblastoma · 182 trials list this drug (37 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02784015Phase 2 · unknown Response Based Treatment for Children With Unresectable Localized Soft Tissue Sarcoma · 182 trials list this drug (37 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02333838Phase 2 · unknown Reduced Toxicity Conditioning Prior to Unrelated Cord Cell Transplantation for High Risk Myeloid Malignancies · 182 trials list this drug (37 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01598025NA · terminated Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor · 182 trials list this drug (37 active) | — | — | Acute Leukemia,Chronic Leukemia,Myelodysplastic Syndrome+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01050764Phase 1/Phase 2 · terminated Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells · 182 trials list this drug (37 active) | — | — | Acute Leukemia,Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006123Phase 1/Phase 2 · withdrawn Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast Cancer · 182 trials list this drug (37 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00593554Phase 2 · terminated Phase 2 Haplotype Mismatched HSCT in Patients With Hematological Malignancies · 182 trials list this drug (37 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00047320Phase 2 · completed Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors · 182 trials list this drug (37 active) | — | — | Central Nervous System Neoplasm,Childhood Germ Cell Tumor,Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02199041Phase 2 · terminated Combined T Cell Depleted Haploidentical Peripheral Blood Stem Cell and Unrelated Umbilical Cord Blood Transplantation in Patients With Hematologic Malignancies Using a Total Lymphoid Irradiation Based Preparative Regimen · 182 trials list this drug (37 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00392782Phase 2 · terminated Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease · 182 trials list this drug (37 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00623077Phase 1 · terminated MT2004-30: Tomotherapy for Solid Tumors · 182 trials list this drug (37 active) | — | — | Sarcoma,Malignant Kidney Neoplasm,Malignant Liver Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003926Phase 1 · terminated Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors · 182 trials list this drug (37 active) | — | — | Childhood Germ Cell Tumor,Chordoma,Sarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101140Phase 2 · withdrawn Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission · 182 trials list this drug (37 active) | — | — | Adult Acute Erythroid Leukemia,Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00238433Phase 2 · completed Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma · 182 trials list this drug (37 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02653196early Phase 1 · terminated A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors · 182 trials list this drug (37 active) | — | — | Solid Neoplasm,Neuroepithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003199Phase 2 · completed Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer · 182 trials list this drug (37 active) | — | — | Malignant Breast Neoplasm,Male Breast Carcinoma,Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02259348Phase 2 · terminated Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation · 182 trials list this drug (37 active) | — | — | Myeloid Sarcoma,Acute Lymphoblastic Leukemia,Juvenile Myelomonocytic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00450983Phase 2 · terminated Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases · 182 trials list this drug (37 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02724904Phase 1/Phase 2 · withdrawn Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (HSCT) For Lymphoma · 182 trials list this drug (37 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00182793Phase 2 · completed Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer · 182 trials list this drug (37 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00824135Phase 1 · completed Haploidentical Hematopoietic Stem Cell Transplantation Using A Novel Clofarabine Containing Conditioning Regimen For Patients With Refractory Hematologic Malignancies · 182 trials list this drug (37 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00104975Phase 1 · completed Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer · 182 trials list this drug (37 active) | — | — | Leukemia,Lymphoma,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003899Phase 1 · completed Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors · 182 trials list this drug (37 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003852Phase 2 · terminated Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors · 182 trials list this drug (37 active) | — | — | Childhood Germ Cell Tumor,Extragonadal Germ Cell Tumor,Testicular Germ Cell Tumor+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02507479Phase 2 · unknown Thiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies · 182 trials list this drug (37 active) | — | — | Hodgkin Lymphoma,Multiple Myeloma,Non-Hodgkin Lymphoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002718Phase 2 · completed T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic Anemia · 182 trials list this drug (37 active) | — | — | Leukemia,Lymphoma,Myelodysplastic Syndrome+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00028730Phase 2 · completed Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic Cancer · 182 trials list this drug (37 active) | — | — | Leukemia,Lymphoma,Myelodysplastic Syndrome+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003273Phase 2 · withdrawn Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor · 182 trials list this drug (37 active) | — | — | Sarcoma,Neuroblastoma,Retinoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00357396Phase 2 · completed Busulfan, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk Ewing's Tumors · 182 trials list this drug (37 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00317408NA · unknown Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma · 182 trials list this drug (37 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004092Phase 2 · completed Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer · 182 trials list this drug (37 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00078988Phase 3 · completed High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomas · 182 trials list this drug (37 active) | — | — | Central Nervous System Neoplasm,Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00916045Phase 2 · terminated Pilot Study of Unrelated Cord Blood Transplantation · 182 trials list this drug (37 active) | — | — | Leukemia,Hodgkin Lymphoma,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002870Phase 3 · completed High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer · 182 trials list this drug (37 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003846Phase 2 · completed Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors · 182 trials list this drug (37 active) | — | — | Central Nervous System Neoplasm,Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01786018Phase 2 · unknown Thiotepa, Busulfan and Fludarabin for pt With Refractory/Early Relapsed Aggressive B-cell Non Hodgkin Lymphomas · 182 trials list this drug (37 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00202917Phase 1/Phase 2 · completed Haploidentical Transplantation With CD3/CD19 Depleted Grafts in Patients With Hematologic Malignancies · 182 trials list this drug (37 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003141Phase 1 · completed Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors · 182 trials list this drug (37 active) | — | — | Central Nervous System Neoplasm,Sarcoma,Brain Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00017368Phase 2 · completed Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma · 182 trials list this drug (37 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02049580Phase 2 · unknown Reduced Intensity Conditioning (RIC) Regimen and Post-transplant Cyclophosphamide in Haploidentical Bone Marrow Transplantation in in Patients With Poor Prognosis Lymphomas · 182 trials list this drug (37 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00303810NA · completed Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma · 182 trials list this drug (37 active) | — | — | Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003064Phase 1/Phase 2 · unknown Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer · 182 trials list this drug (37 active) | — | — | Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00012311Phase 2 · unknown Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer · 182 trials list this drug (37 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002780Phase 1/Phase 2 · unknown Biological Therapy in Treating Women With Metastatic Breast Cancer · 182 trials list this drug (37 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025324Phase 2 · unknown Chemotherapy, Surgery, Radiation Therapy and Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Primary CNS Germ Cell Tumors · 182 trials list this drug (37 active) | — | — | Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00392886Phase 3 · unknown Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors · 182 trials list this drug (37 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00462787Phase 1 · completed Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Leukemia · 182 trials list this drug (37 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002755Phase 3 · completed Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer · 182 trials list this drug (37 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003680Phase 3 · unknown Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer · 182 trials list this drug (37 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002616Phase 1 · unknown Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer · 182 trials list this drug (37 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00313521Phase 2 · unknown Thiotepa and Radiation Therapy in Treating Young Patients With Newly Diagnosed Malignant Brain Tumors · 182 trials list this drug (37 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025077Phase 2 · completed Combination Chemotherapy, Surgery or Radiation Therapy, and Peripheral Stem Cell Transplant in Treating Patients With Recurrent Medulloblastoma or Primitive Neuroectodermal and Pineal Tumors · 182 trials list this drug (37 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002680Phase 2 · completed Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer · 182 trials list this drug (37 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004174Phase 1 · completed Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer · 182 trials list this drug (37 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002534Phase 3 · completed Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second Remission · 182 trials list this drug (37 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003101Phase 2 · completed Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma · 182 trials list this drug (37 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002515Phase 2 · completed Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer · 182 trials list this drug (37 active) | — | — | Childhood Germ Cell Tumor,Extragonadal Germ Cell Tumor,Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00045539Phase 2 · completed Methotrexate and Thiotepa in Treating Patients With Newly Diagnosed Primary CNS Lymphoma · 182 trials list this drug (37 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002471Phase 2 · completed Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma · 182 trials list this drug (37 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004900Phase 2 · completed Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer · 182 trials list this drug (37 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004906Phase 2 · completed Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer · 182 trials list this drug (37 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00060255Phase 2 · completed High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors · 182 trials list this drug (37 active) | — | — | Adult Solid Neoplasm,Childhood Solid Neoplasm,Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00066417Phase 2 · terminated Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia · 182 trials list this drug (37 active) | — | — | Leukemia,Myelodysplastic/Myeloproliferative Neoplasm,Myeloproliferative Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00429182Phase 2 · completed Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer · 182 trials list this drug (37 active) | — | — | Malignant Breast Neoplasm,Breast Carcinoma,Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01810926Phase 2 · unknown T&B Depletion Non Malignant · 182 trials list this drug (37 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003173Phase 2 · completed High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors · 182 trials list this drug (37 active) | — | — | Adult Solid Neoplasm,Childhood Germ Cell Tumor,Childhood Solid Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00040872Phase 2 · completed Multiple Therapies in Treating Patients With Advanced Neuroblastoma · 182 trials list this drug (37 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00007982Phase 2 · completed Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer · 182 trials list this drug (37 active) | — | — | Lymphoma,Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00008008Phase 2 · completed Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma · 182 trials list this drug (37 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00008203Phase 3 · completed Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer · 182 trials list this drug (37 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002704Phase 2 · completed Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia · 182 trials list this drug (37 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003068Phase 2 · completed High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer · 182 trials list this drug (37 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002772Phase 3 · terminated S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer · 182 trials list this drug (37 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00295971Phase 1 · completed Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease · 182 trials list this drug (37 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002619Phase 2 · completed Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Glioblastoma Multiforme or Brain Stem Tumors · 182 trials list this drug (37 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005798Phase 2 · completed Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer · 182 trials list this drug (37 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00972101Phase 1 · withdrawn Infusion of Expanded Cord Blood T Cells · 182 trials list this drug (37 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00038857Phase 2 · completed Megadose CD34 Selected Progenitor Cells for Transplantation in Patients With Advanced Hematological Malignant Diseases · 182 trials list this drug (37 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004172Phase 2 · completed Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer · 182 trials list this drug (37 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003146Phase 2 · completed Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma · 182 trials list this drug (37 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025558Phase 1 · completed Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer · 182 trials list this drug (37 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003297Phase 1/Phase 2 · completed Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Cancer · 182 trials list this drug (37 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003877Phase 1/Phase 2 · completed Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer · 182 trials list this drug (37 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112567Phase 1/Phase 2 · completed Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer · 182 trials list this drug (37 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003081Phase 1 · completed Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or Rhabdomyosarcoma · 182 trials list this drug (37 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002977Phase 1 · completed Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission · 182 trials list this drug (37 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003080Phase 1 · completed Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer · 182 trials list this drug (37 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00027937Phase 2 · completed Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or Lymphoma · 182 trials list this drug (37 active) | — | — | Adult Solid Neoplasm,Childhood Solid Neoplasm,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003972Phase 3 · completed Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer · 182 trials list this drug (37 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00647049Phase 2 · unknown Freiburg ZNS-NHL Study · 182 trials list this drug (37 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |